SARS-CoV-2 correlates of protection from infection against variants of concern
Kaiyuan Sun, Jinal N. Bhiman, Stefano Tempia, Jackie Kleynhans, Vimbai Sharon Madzorera, Qiniso Mkhize, Haajira Kaldine, Meredith L McMorrow, Nicole Wolter, Jocelyn Moyes, Maimuna Carrim, Neil A Martinson, Kathleen Kahn, Limakatso Lebina, Jacques D. du Toit, Thulisa Mkhencele, Anne von Gottberg, Cécile Viboud, Penny L. Moore, View ORCID ProfileCheryl Cohen, PHIRST-C group
doi: https://doi.org/10.1101/2024.05.28.24308095
Kaiyuan Sun
1Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America
Jinal N. Bhiman
2SAMRC Antibody Immunity Research Unit, University of the Witwatersrand, Johannesburg, South Africa
3Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
Stefano Tempia
4Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
5School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
6Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Jackie Kleynhans
4Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
5School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Vimbai Sharon Madzorera
2SAMRC Antibody Immunity Research Unit, University of the Witwatersrand, Johannesburg, South Africa
3Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
Qiniso Mkhize
2SAMRC Antibody Immunity Research Unit, University of the Witwatersrand, Johannesburg, South Africa
3Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
Haajira Kaldine
2SAMRC Antibody Immunity Research Unit, University of the Witwatersrand, Johannesburg, South Africa
3Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
Meredith L McMorrow
6Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
8COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
Nicole Wolter
4Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
7School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Jocelyn Moyes
4Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
5School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Maimuna Carrim
4Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
7School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Neil A Martinson
9Perinatal HIV Research Unit, University of the Witwatersrand, South Africa
10Johns Hopkins University Center for TB Research, Baltimore, Maryland, United States of America
Kathleen Kahn
11MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Limakatso Lebina
9Perinatal HIV Research Unit, University of the Witwatersrand, South Africa
Jacques D. du Toit
11MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Thulisa Mkhencele
4Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
Anne von Gottberg
4Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
7School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Cécile Viboud
1Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America
Penny L. Moore
2SAMRC Antibody Immunity Research Unit, University of the Witwatersrand, Johannesburg, South Africa
3Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
12Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
Cheryl Cohen
4Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
5School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Article usage
Posted June 07, 2024.
SARS-CoV-2 correlates of protection from infection against variants of concern
Kaiyuan Sun, Jinal N. Bhiman, Stefano Tempia, Jackie Kleynhans, Vimbai Sharon Madzorera, Qiniso Mkhize, Haajira Kaldine, Meredith L McMorrow, Nicole Wolter, Jocelyn Moyes, Maimuna Carrim, Neil A Martinson, Kathleen Kahn, Limakatso Lebina, Jacques D. du Toit, Thulisa Mkhencele, Anne von Gottberg, Cécile Viboud, Penny L. Moore, Cheryl Cohen, PHIRST-C group
medRxiv 2024.05.28.24308095; doi: https://doi.org/10.1101/2024.05.28.24308095
SARS-CoV-2 correlates of protection from infection against variants of concern
Kaiyuan Sun, Jinal N. Bhiman, Stefano Tempia, Jackie Kleynhans, Vimbai Sharon Madzorera, Qiniso Mkhize, Haajira Kaldine, Meredith L McMorrow, Nicole Wolter, Jocelyn Moyes, Maimuna Carrim, Neil A Martinson, Kathleen Kahn, Limakatso Lebina, Jacques D. du Toit, Thulisa Mkhencele, Anne von Gottberg, Cécile Viboud, Penny L. Moore, Cheryl Cohen, PHIRST-C group
medRxiv 2024.05.28.24308095; doi: https://doi.org/10.1101/2024.05.28.24308095
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2854)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12562)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4437)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2851)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4196)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6784)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)